These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 29803392

  • 1. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
    Albano D, Patti C, Matranga D, Lagalla R, Midiri M, Galia M.
    Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
    [Abstract] [Full Text] [Related]

  • 2. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C, Gallamini A, Stracqualursi L, Agati P, Tripodo C, Fuligni F, Sista MT, Fanti S, Biggi A, Vitolo U, Rigacci L, Merli F, Patti C, Romano A, Levis A, Trentin L, Stelitano C, Borra A, Piccaluga PP, Hamilton-Dutoit S, Kamper P, Zaucha JM, Małkowski B, Kulikowski W, Tajer J, Subocz E, Rybka J, Steidl C, Broccoli A, Argnani L, Gascoyne RD, d'Amore F, Zinzani PL, Pileri SA.
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [Abstract] [Full Text] [Related]

  • 3. Whole-Body Diffusion-Weighted MRI Compared to 18 FFDG PET/CT in Initial Staging and Therapy Response Assessment of Hodgkin Lymphoma in Pediatric Patients.
    Shapira-Zaltsberg G, Wilson N, Trejo Perez E, Abbott L, Dinning S, Kapoor C, Davila J, Smith B, Miller E.
    Can Assoc Radiol J; 2020 May; 71(2):217-225. PubMed ID: 32062992
    [Abstract] [Full Text] [Related]

  • 4. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
    Ciammella P, Filippi AR, Simontacchi G, Buglione M, Botto B, Mangoni M, Iotti C, Merli F, Marcheselli L, Bisi G, Ricardi U, Versari A.
    Br J Radiol; 2016 May; 89(1061):20150983. PubMed ID: 27022777
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.
    Chiaravalloti A, Danieli R, Abbatiello P, Di Pietro B, Travascio L, Cantonetti M, Guazzaroni M, Orlacchio A, Simonetti G, Schillaci O.
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1123-32. PubMed ID: 24562647
    [Abstract] [Full Text] [Related]

  • 8. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 9. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.
    Simontacchi G, Filippi AR, Ciammella P, Buglione M, Saieva C, Magrini SM, Livi L, Iotti C, Botto B, Vaggelli L, Re A, Merli F, Ricardi U.
    Int J Radiat Oncol Biol Phys; 2015 Aug 01; 92(5):1077-1083. PubMed ID: 26031367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
    Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, Akin O, Linch D, Ardeshna K, Lambert J, Miles K, Groves A, Kayani I.
    Clin Nucl Med; 2017 Jan 01; 42(1):e1-e7. PubMed ID: 27607161
    [Abstract] [Full Text] [Related]

  • 12. FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
    Cheson BD, Kostakoglu L.
    Oncology (Williston Park); 2017 Jan 15; 31(1):45-9. PubMed ID: 28090622
    [Abstract] [Full Text] [Related]

  • 13. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
    Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW.
    J Clin Oncol; 2016 Jun 10; 34(17):2020-7. PubMed ID: 27069074
    [Abstract] [Full Text] [Related]

  • 14. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H.
    Clin Radiol; 2015 Nov 10; 70(11):1229-36. PubMed ID: 26208992
    [Abstract] [Full Text] [Related]

  • 15. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
    Atkinson W, Catana C, Abramson JS, Arabasz G, McDermott S, Catalano O, Muse V, Blake MA, Barnes J, Shelly M, Hochberg E, Rosen BR, Guimaraes AR.
    Abdom Radiol (NY); 2016 Jul 10; 41(7):1338-48. PubMed ID: 27315095
    [Abstract] [Full Text] [Related]

  • 16. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D, Patti C, Lagalla R, Midiri M, Galia M.
    J Magn Reson Imaging; 2017 Apr 10; 45(4):1082-1089. PubMed ID: 27603267
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.
    Mesguich C, Cazeau AL, Bouabdallah K, Soubeyran P, Guyot M, Milpied N, Bordenave L, Hindié E.
    Br J Haematol; 2016 Nov 10; 175(4):652-660. PubMed ID: 27539369
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.